List of Clinuvel Pharmaceuticals Ltd patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11622994 Therapy for vitiligo	Patent 11622994 was granted and assigned to Clinuvel Pharmaceuticals Ltd on April, 2023 by the United States Patent and Trademark Office.	Clinuvel Pharmaceuticals Ltd	Clinuvel Pharmaceuticals Ltd	United States Patent and Trademark Office	11622994	April 11, 2023
‌ US Patent 10076555 Methods of inducing melanogenesis in a subject	Patent 10076555 was granted and assigned to Clinuvel Pharmaceuticals Ltd on September, 2018 by the United States Patent and Trademark Office.	Clinuvel Pharmaceuticals Ltd	Clinuvel Pharmaceuticals Ltd	United States Patent and Trademark Office	10076555	September 18, 2018
‌ US Patent 9801924 Therapy for vitiligo	Patent 9801924 was granted and assigned to Clinuvel Pharmaceuticals Ltd on October, 2017 by the United States Patent and Trademark Office.	Clinuvel Pharmaceuticals Ltd	Clinuvel Pharmaceuticals Ltd	United States Patent and Trademark Office	9801924	October 31, 2017
‌ US Patent 9345911 Methods of inducing melanogenesis in a subject	Patent 9345911 was granted and assigned to Clinuvel Pharmaceuticals Ltd on May, 2016 by the United States Patent and Trademark Office.		Clinuvel Pharmaceuticals Ltd	United States Patent and Trademark Office	9345911	May 24, 2016
‌ US Patent 8569234 Compositions and methods for including melanogenesis in a subject			Clinuvel Pharmaceuticals Ltd	United States Patent and Trademark Office	8569234	October 29, 2013
‌ US Patent 8334265 Method of treatment of photodermatoses	Patent 8334265 was granted and assigned to Clinuvel Pharmaceuticals Ltd on December, 2012 by the United States Patent and Trademark Office.		Clinuvel Pharmaceuticals Ltd	United States Patent and Trademark Office	8334265	December 18, 2012